Education
About Us
Working with TipRanks
Follow Us
OrthoPediatrics Corp (KIDS)
NASDAQ:KIDS
KIDS Stock Chart & Stats
$16.96
-$0.10(-0.41%)
At close: 4:00 PM EST
$16.96
-$0.10(-0.41%)
Day’s Range― - ―
52-Week Range$15.28 - $26.40
Previous CloseN/A
Volume20.12K
Average Volume (3M)196.93K
Market Cap
$428.57M
Enterprise Value$507.83M
Total Cash (Recent Filing)$57.73M
Total Debt (Recent Filing)$99.34M
Price to Earnings (P/E)―
Beta0.66
Next Earnings
Feb 26, 2026EPS Estimate
-0.29Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.24
Shares Outstanding25,077,330
10 Day Avg. Volume194,659
30 Day Avg. Volume196,931
Financial Highlights & Ratios
PEG Ratio-0.18
Price to Book (P/B)1.51
Price to Sales (P/S)2.61
P/FCF Ratio-12.95
Enterprise Value/Market Cap1.18
Enterprise Value/Revenue2.23
Enterprise Value/Gross Profit3.11
Enterprise Value/Ebitda-35.22
Forecast
1Y Price Target
$26.00Price Target Upside53.30% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Improving Cash Generation And Financial ProfileAnalyst observes the company has moved to adjusted EBITDA positive and generated positive free cash flow, reducing cash usage and strengthening the financial profile that could support valuation multiple expansion.
Market Leadership And Competitive MoatAnalyst notes exclusive focus on pediatric orthopedics and limited direct competition from firms adapting adult implants creates a defensible market position and opportunity to capture outsized share in trauma, deformity, and scoliosis.
Regulatory Approval And International ExpansionAnalyst highlights European regulatory certification for the spine and trauma device portfolio enables broader market access and supports accelerated international growth.
Bears Say
Profitability Guidance RiskAnalyst warns guidance for adjusted profitability below market expectations could pressure near-term earnings forecasts and investor sentiment.
Reduced Surgical Set DeploymentAnalyst cautions planned lower deployment of surgical sets may slow surgeon adoption of new products and constrain revenue growth, raising execution risk.
Revenue Volatility And Negative RevisionsAnalyst notes periodic revenue volatility and the impact of negative revisions can weigh on investor sentiment and suppress valuation until trends stabilize.
OrthoPediatrics News
KIDS FAQ
What was OrthoPediatrics Corp’s price range in the past 12 months?
OrthoPediatrics Corp lowest stock price was $15.28 and its highest was $26.40 in the past 12 months.
What is OrthoPediatrics Corp’s market cap?
OrthoPediatrics Corp’s market cap is $428.57M.
When is OrthoPediatrics Corp’s upcoming earnings report date?
OrthoPediatrics Corp’s upcoming earnings report date is Feb 26, 2026 which is in 3 days.
How were OrthoPediatrics Corp’s earnings last quarter?
OrthoPediatrics Corp released its earnings results on Oct 28, 2025. The company reported -$0.24 earnings per share for the quarter, beating the consensus estimate of -$0.258 by $0.018.
Is OrthoPediatrics Corp overvalued?
According to Wall Street analysts OrthoPediatrics Corp’s price is currently Undervalued.
Does OrthoPediatrics Corp pay dividends?
OrthoPediatrics Corp does not currently pay dividends.
What is OrthoPediatrics Corp’s EPS estimate?
OrthoPediatrics Corp’s EPS estimate is -0.29.
How many shares outstanding does OrthoPediatrics Corp have?
OrthoPediatrics Corp has 25,077,330 shares outstanding.
What happened to OrthoPediatrics Corp’s price movement after its last earnings report?
OrthoPediatrics Corp reported an EPS of -$0.24 in its last earnings report, beating expectations of -$0.258. Following the earnings report the stock price went down -2.661%.
Which hedge fund is a major shareholder of OrthoPediatrics Corp?
Currently, no hedge funds are holding shares in KIDS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
OrthoPediatrics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$26.00 (53.30% Upside)
$26.00 (53.30% Upside)
Blogger Sentiment
Bullish
KIDS Sentiment 100%
Sector Average 70%
Sector Average 70%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-22.43%
12-Months-Change
Fundamentals
Return on Equity
-12.67%
Trailing 12-Months
Asset Growth
0.86%
Trailing 12-Months
Company Description
OrthoPediatrics Corp
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.
KIDS Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted strong financial and operational performance, including record revenue growth and successful strategic expansions in key market segments such as Scoliosis and OPSB. However, there were challenges such as a decline in gross margin, slower than expected T&D growth, and restructuring charges. Overall, the positive aspects of the company's performance and future outlook significantly outweigh the negatives.View all KIDS earnings summariesKIDS Stock 12 Month Forecast
Average Price Target
$26.00
▲(53.30% Upside)
Technical Analysis
Orthofix Medical
―
Tandem Diabetes Care
―
Varex Imaging
―
Bioventus
―
Treace Medical Concepts
―
Ownership Overview
32.72% Insiders
14.71% Mutual Funds
21.16% Other Institutional Investors
23.61% Public Companies and
Individual Investors